IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 21 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $175,000 | -74.5% | 30,838 | -87.5% | 0.01% | -67.5% |
Q3 2018 | $687,000 | +82.7% | 247,117 | +44.5% | 0.04% | +66.7% |
Q2 2018 | $376,000 | +216.0% | 170,962 | +153.8% | 0.02% | +200.0% |
Q1 2018 | $119,000 | -62.3% | 67,355 | -63.8% | 0.01% | -60.0% |
Q4 2017 | $316,000 | +54.1% | 186,214 | +46.4% | 0.02% | +53.8% |
Q3 2017 | $205,000 | -77.3% | 127,214 | -55.0% | 0.01% | -78.7% |
Q2 2017 | $905,000 | -27.0% | 282,654 | -4.9% | 0.06% | -28.2% |
Q1 2017 | $1,239,000 | +249.0% | 297,297 | +109.0% | 0.08% | +226.9% |
Q4 2016 | $355,000 | -42.1% | 142,226 | -11.6% | 0.03% | -43.5% |
Q3 2016 | $613,000 | +5.0% | 160,876 | +3.7% | 0.05% | 0.0% |
Q2 2016 | $584,000 | -3.0% | 155,190 | +2.4% | 0.05% | -16.4% |
Q1 2016 | $602,000 | -30.6% | 151,510 | +21.0% | 0.06% | -29.5% |
Q4 2015 | $868,000 | -25.2% | 125,251 | -30.7% | 0.08% | -29.7% |
Q3 2015 | $1,160,000 | +10.1% | 180,768 | +39.5% | 0.11% | +14.4% |
Q2 2015 | $1,054,000 | -18.8% | 129,627 | -20.2% | 0.10% | -13.4% |
Q1 2015 | $1,298,000 | +43.3% | 162,490 | +34.5% | 0.11% | +9.8% |
Q4 2014 | $906,000 | +147.5% | 120,791 | +144.9% | 0.10% | +104.0% |
Q3 2014 | $366,000 | +83.9% | 49,320 | +72.2% | 0.05% | +78.6% |
Q2 2014 | $199,000 | – | 28,649 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,722,000 | $9,798,000 | 3.66% |
Diametric Capital, LP | 252,160 | $1,453,000 | 1.12% |
Birchview Capital, LP | 180,000 | $1,024,000 | 0.97% |
EAM Global Investors LLC | 206,445 | $1,175,000 | 0.64% |
EAM Investors, LLC | 301,415 | $1,715,000 | 0.47% |
BARD ASSOCIATES INC | 51,550 | $293,000 | 0.17% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 85,569 | $487,000 | 0.11% |
ARDSLEY ADVISORY PARTNERS LP | 75,000 | $427,000 | 0.11% |
PRELUDE CAPITAL MANAGEMENT, LLC | 112,859 | $642,000 | 0.04% |
ELLINGTON MANAGEMENT GROUP LLC | 16,500 | $94,000 | 0.03% |